Patent - newshttp://www.managingip.com/RSS.aspx?FeedID=2848©2018 Managing Intellectual Property60Patent - newsFour effective US patent marking proceduresBinal Patel and Kirk Sigmon discuss strategies that companies can use to mark products with indications of applicable patentshttp://www.managingip.com/Article/3807989/Four-effective-US-patent-marking-procedures.htmlFri, 18 May 2018 16:15:00 GMTSteering clear of five common US patent marking trapsBinal Patel and Kirk Sigmon discuss common patent marking pitfalls in the US, offering advice on how to avoid themhttp://www.managingip.com/Article/3807988/Steering-clear-of-five-common-US-patent-marking-traps.htmlFri, 18 May 2018 16:00:00 GMTFederal Circuit issues two patent venue mandamus rulingsThe plaintiff bears the burden of proving venue in patent cases and venue is only proper for a corporation registered in a multiple district-state in the district where it has its principal place of business, the Federal Circuit ruled in ZTE and BigCommercehttp://www.managingip.com/Article/3807456/Federal-Circuit-issues-two-patent-venue-mandamus-rulings.htmlWed, 16 May 2018 22:45:00 GMTThe Guangdong High People’s Court guideline for SEP disputes: a primerBen Ni of King & Wood Mallesons gives an overview of the guideline for trial of standard essential patent dispute cases, which incorporates rules established in cases worldwidehttp://www.managingip.com/Article/3807163/The-Guangdong-High-Peoples-Court-guideline-for-SEP-disputes-a-primer.htmlTue, 15 May 2018 17:15:00 GMTHow PTAB claim construction change will affect proceedingsPatent owners may not benefit from the proposed shift to the Phillips claim construction standard at the PTAB if it reduces the chance of a stay and leads to a less nuanced Markman constructionhttp://www.managingip.com/Article/3806955/How-PTAB-claim-construction-change-will-affect-proceedings.htmlTue, 15 May 2018 05:15:00 GMTHow the Federal Circuit's WesternGeco ruling affects the Supreme Court caseThe Federal Circuit has affirmed the PTAB’s invalidation of claims of three patents involved in the WesternGeco v Ion case at the Supreme Courthttp://www.managingip.com/Article/3806929/How-the-Federal-Circuits-WesternGeco-ruling-affects-the-Supreme-Court-case.htmlMon, 14 May 2018 20:30:00 GMTKorea’s law amendment aims to strengthen trade dress protectionChanges to Korea’s Unfair Competition Prevention Act follow a 2016 Supreme Court ruling relating to trade dresshttp://www.managingip.com/Article/3806924/Koreas-law-amendment-aims-to-strengthen-trade-dress-protection.htmlMon, 14 May 2018 18:30:00 GMTInterview: Ant Financial’s Benjamin Bai on blockchain and AIThe chief IP counsel of the fintech leader tells Managing IP about the challenges of blockchain and AI patent filinghttp://www.managingip.com/Article/3806650/Interview-Ant-Financials-Benjamin-Bai-on-blockchain-and-AI.htmlFri, 11 May 2018 21:30:00 GMTHatch-Waxman filing in Delaware surged 60% in 2017Hatch-Waxman pharma patent litigation filings last year rose to near-2015 levels. Lex Machina’s new ANDA litigation report also reveals data on judges, plaintiffs, defendants and law firmshttp://www.managingip.com/Article/3806295/Hatch-Waxman-filing-in-Delaware-surged-60-in-2017.htmlFri, 11 May 2018 00:15:00 GMTWomen in IP Global Network Interview: Imogen Fowler, Mireille Buydens and Ellen ShankmanFor this edition of the Women in IP Interview, Lucy Songi speaks to Imogen Fowler (Hogan Lovells), Mireille Buydens (Janson Baugniet) and Ellen Shankman (Ellen B Shankman & Associates) about their experiences and what advice they would offer to up-and-coming IP practitionershttp://www.managingip.com/Article/3805977/Women-in-IP-Global-Network-Interview-Imogen-Fowler-Mireille-Buydens-and-Ellen-Shankman.htmlWed, 09 May 2018 16:45:00 GMTAnalysing the CRISPR arguments at the Federal CircuitThe UC v Broad Institute appeal hinges on whether the PTAB made any legal errors by deciding the case in favour of Broad without "substantial evidence", with observers believing an affirmance of the Board's ruling is most likelyhttp://www.managingip.com/Article/3805555/Analysing-the-CRISPR-arguments-at-the-Federal-Circuit.htmlTue, 08 May 2018 15:45:00 GMTProfile interview: Jerry Xia, chief IP counsel, APAC at HoneywellManaging IP learns about the challenges of trade secret litigation, OEM trade mark infringement and other trends in China from the conglomerate's chief IP counselhttp://www.managingip.com/Article/3805553/Profile-interview-Jerry-Xia-chief-IP-counsel-APAC-at-Honeywell.htmlTue, 08 May 2018 15:45:00 GMTNegotiating SEP licences in Europe after Huawei v ZTE: guidance from national courtsDr Claudia Tapia and Dr Spyros Makris provide an overview of the case law of national courts in Europe exploring the framework for licensing negotiations regarding FRAND-accessible standard essential patents, which was established by the decision of the CJEU in the matter Huawei v ZTEhttp://www.managingip.com/Article/3804014/Negotiating-SEP-licences-in-Europe-after-Huawei-v-ZTE-guidance-from-national-courts.htmlFri, 04 May 2018 12:00:00 GMTUtynam’s HeirsUtynam attended the Fordham IP Conference 2018 in April. Here are some highlights.http://www.managingip.com/Article/3804350/Utynams-Heirs.htmlThu, 03 May 2018 12:00:00 GMTStart-ups’ specific IP challengesLack of experience and funds mean intellectual property is often neglected by start-ups. Managing IP asks a few of them how they approach IP strategyhttp://www.managingip.com/Article/3804619/Start-ups-specific-IP-challenges.htmlThu, 03 May 2018 00:15:00 GMTRPX sale agreed in $555m dealThe sale of RPX to HGGC at $10.50 per share follows a review of strategic alternatives by the boardhttp://www.managingip.com/Article/3804224/RPX-sale-agreed-in-555m-deal.htmlTue, 01 May 2018 20:00:00 GMTThe patent implications of China’s generics pushInnovator drug companies will face challenges but complementary guidelines benefiting innovators, including a potential five-year patent term extension, may pacify concernshttp://www.managingip.com/Article/3803904/The-patent-implications-of-Chinas-generics-push.htmlMon, 30 Apr 2018 17:45:00 GMTAG weighs in on SPCs in Teva v Gilead opinionAdvocate General Wathelet has rejected the UK court’s suggestion that “core inventive advance” is a relevant consideration in determining whether a basic patent protects an active ingredient within the meaning of Article 3(a)http://www.managingip.com/Article/3803600/AG-weighs-in-on-SPCs-in-Teva-v-Gilead-opinion.htmlFri, 27 Apr 2018 16:30:00 GMTUSPTO releases guidance on SAS impact on PTAB proceedingsGuidance includes stipulating that for pending trials in which a panel has instituted only on some challenges in the petition, the panel may issue an order supplementing the institution decision to institute on all challenges raised in the petitionhttp://www.managingip.com/Article/3803395/USPTO-releases-guidance-on-SAS-impact-on-PTAB-proceedings.htmlFri, 27 Apr 2018 14:45:00 GMTUK ratifies Unified Patent Court agreement – now what?The UK government ratifying the agreement to establish a Unified Patent Court for Europe shows it is serious about the court. The big uncertainty now is a German constitutional complaint against the UPChttp://www.managingip.com/Article/3803312/UK-ratifies-Unified-Patent-Court-agreementnow-what.htmlFri, 27 Apr 2018 13:15:00 GMTThe Top 250 Women in IP (2018)Managing IP presents this year’s leading female intellectual property practitioners, according to IP STARS researchhttp://www.managingip.com/Article/3802643/The-Top-250-Women-in-IP-2018.htmlThu, 26 Apr 2018 08:00:00 GMTIn-house tips for patent enforcement in EuropeIn-house counsel in Europe explain to Patrick Wingrove how they decide when to enforce their patent portfolioshttp://www.managingip.com/Article/3802897/In-house-tips-for-patent-enforcement-in-Europe.htmlThu, 26 Apr 2018 07:30:00 GMTSCOTUS abolishes PTAB practice of partial claim reviewThe US Supreme Court has decided in SAS Institute v Iancu that the PTAB must review all or none of the challenged claims. Observers say the PTAB petitioners could react to the ruling in a number of ways, and it “may increase the number of issues that bubble up to the Federal Circuit”http://www.managingip.com/Article/3802755/SCOTUS-abolishes-PTAB-practice-of-partial-claim-review.htmlWed, 25 Apr 2018 15:00:00 GMTSupreme Court finds IPRs constitutional, 7-2The US Supreme Court has ruled the IPR process at the Patent Trial and Appeal Board is constitutional, although two justices dissented and the court left IPRs open to due process argumentshttp://www.managingip.com/Article/3802750/Supreme-Court-finds-IPRs-constitutional-7-2.htmlWed, 25 Apr 2018 15:00:00 GMTIn-house counsel reflect on “blood sport” of litigating and licensing SEPs in EuropeRecent standard essential patent developments include hopes for courts to “show muscle” in granting injunctions, the European Commission’s recent communication and proposals for alternative dispute resolutionshttp://www.managingip.com/Article/3802625/In-house-counsel-reflect-on-blood-sport-of-litigating-and-licensing-SEPs-in-Europe.htmlWed, 25 Apr 2018 09:15:00 GMTSome highlights from our European Life Sciences ForumThe UPC, second medical use patents, the doctrine of equivalents, SPCs, AI and much more were discussed at the European Life Sciences Forumhttp://www.managingip.com/Article/3802627/Some-highlights-from-our-European-Life-Sciences-Forum.htmlWed, 25 Apr 2018 09:00:00 GMTLatest IP people moves in North America and EuropeRecent intellectual people moves include Marks & Clerk Canada combining with two Toronto firms, and hires by Sheppard Mullin, Arnold & Porter, King & Spalding, Fish & Richardson, Vossius & Partner and morehttp://www.managingip.com/Article/3801692/Latest-IP-people-moves-in-North-America-and-Europe.htmlThu, 19 Apr 2018 20:15:00 GMTIndia moves towards Form 27 reformIndia’s Patent Office is gathering input on reforming Form 27. IP practitioners hope changes to the burdensome statement regarding the working of the patented invention will come this yearhttp://www.managingip.com/Article/3801680/India-moves-towards-Form-27-reform.htmlThu, 19 Apr 2018 18:45:00 GMTSchizophrenia drug patent survives Section 101 test at Federal CircuitIn its important Vanda Pharmaceuticals v West-Ward Pharmaceuticals opinion, the Federal Circuit found the claims eligible at step two of the Mayo/Alice test whereas the district court found them eligible at step onehttp://www.managingip.com/Article/3801536/Schizophrenia-drug-patent-survives-Section-101-test-at-Federal-Circuit.htmlThu, 19 Apr 2018 05:30:00 GMTWhat will become of Australia’s innovation patent system?Abolition of Australia’s innovation patent system is still possible but potential options to improve it are also not ruled outhttp://www.managingip.com/Article/3801255/What-will-become-of-Australias-innovation-patent-system.htmlWed, 18 Apr 2018 02:45:00 GMT